A detailed history of Westwood Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Westwood Wealth Management holds 1,940 shares of LLY stock, worth $1.7 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
1,940
Previous 1,615 20.12%
Holding current value
$1.7 Million
Previous $1.26 Million 39.81%
% of portfolio
0.7%
Previous 0.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $235,582 - $295,438
325 Added 20.12%
1,940 $1.76 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $956,403 - $1.28 Million
1,615 New
1,615 $1.26 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Westwood Wealth Management Portfolio

Follow Westwood Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Wealth Management with notifications on news.